Method establishment for content determination of related substances in Oxcarbazepine tablets
- VernacularTitle:奥卡西平片中有关物质含量测定方法的建立
- Author:
Minmin BAO
1
;
Beibei LYU
2
;
Wenzhi WEI
2
;
Minjuan ZHANG
2
Author Information
1. School of Medicine，Qinghai University，Xining 810016，China
2. Qinghai Provincial Drug Inspection and Testing Institute/Qinghai Provincial Key Laboratory of Modernization of Traditional Chinese and Tibetan Medicine/NMPA Key Laboratory for Quality Control of Traditional Chinese Medicine （Tibetan Medicine），Xining 810016，China
- Publication Type:Journal Article
- Keywords:
Oxcarbazepine tablets;
UPLC;
related substance;
content determination
- From:
China Pharmacy
2023;34(10):1199-1203
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To establish the method for content determination of related substances in Oxcarbazepine tablets. METHODS Ultra-high performance liquid chromatography （UPLC） method was adopted and the separation was performed on ZORBAX Eclipse Plus C18 column with mobile phase consisted of acetonitrile-0.01 mol/L ammonium acetate solution （pH6.0） （gradient elution） at the flow rate of 0.5 mL/min. The detection wavelength was 230 nm and column temperature was set at 35 ℃. The sample size was 10 μL. RESULTS The linear ranges of oxcarbazepine and impurity A， B， C， D， E， I， K， L and N were 0.192-1.440， 1.019-7.639， 0.208-1.559， 0.230-1.727， 0.389-2.915， 0.182-1.364， 0.393-2.945， 0.199-1.493， 0.199-1.490 and 0.200- 1.503 μg/mL， respectively （all r＞0.999）. The detection limits were 0.046， 0.037， 0.049， 0.027， 0.077， 0.040， 0.114， 0.054， 0.055 and 0.039 μg/mL. The quantitation limits were 0.152， 0.122， 0.162， 0.090， 0.258， 0.132， 0.380， 0.181， 0.185 and 0.130 μg/mL. RSDs of precision， repeatability， stability （24 h） and durability tests were all lower than 5.0%. The average recoveries were 92.8%-105.6% （RSD≤3.0%， n＝9）. Only impurity K and unknown impurity were detected in the original preparation sample， with a total content of 0.078% to 0.083%； impurities A， B， D， I and unknown impurity were detected in the generic preparations produced by domestic enterprise Ⅰ， with a total content of 0.147% to 0.163%； impurities A， B， I and unknown impurity were detected in the generic preparations produced by domestic enterprise Ⅱ， with a total content of 0.085% to 0.161%. CONCLUSIONS The established method is rapid， sensitive， accurate， stable and durable. It can be used for the content determination of 9 known impurities in Oxcarbazepine tablets.
